For an inpatient with HbA1c 6.9% and no prior insulin use, normal renal function, and not on high‑dose glucocorticoids, what is the appropriate starting insulin dose?

Insulin Dosing for Inpatient with HbA1c 6.9%

For an insulin-naive inpatient with HbA1c 6.9% (indicating good baseline control), start with a basal-plus approach using 0.1–0.25 U/kg/day of basal insulin plus correctional insulin for hyperglycemia, rather than a full basal-bolus regimen. 1

Rationale for Conservative Approach

An HbA1c of 6.9% indicates relatively good glycemic control, which places this patient in the category of "mild hyperglycemia" (blood glucose <200 mg/dL). 1 For such patients:

• Basal-plus regimen is preferred over basal-bolus to avoid overtreatment and reduce hypoglycemia risk 1
• The basal-bolus approach carries a 12-30% incidence of mild hypoglycemia and a 4-6 times higher risk of hypoglycemia compared to sliding scale alone 1
• Patients with good metabolic control on oral agents at home may only require sliding scale insulin alone initially 1

Specific Dosing Algorithm

Initial Basal Insulin Dose:

• Start with 0.1–0.25 U/kg/day of basal insulin (given once daily) 1
• For a 70 kg patient, this equals 7–17.5 units daily
• Use the lower end (0.1 U/kg) if the patient is elderly (>65 years), has renal impairment, or has poor oral intake 1

Correctional Insulin:

• Add rapid-acting insulin for glucose elevations before meals or every 6 hours if NPO 1
• Use a sliding scale for correction doses only when glucose exceeds target

When to Escalate:

• Add basal insulin only if unable to maintain glucose <180 mg/dL (10.0 mmol/L) with sliding scale alone 1
• If basal insulin alone is insufficient after titration, then consider advancing to basal-bolus (0.3–0.5 U/kg/day total, split 50/50 between basal and prandial) 1

Critical Pitfalls to Avoid

Do not use basal-bolus regimen initially – This patient's HbA1c suggests they don't require aggressive insulin therapy, and basal-bolus would expose them to unnecessary hypoglycemia risk 1

Avoid premixed insulin (70/30) – This formulation has unacceptably high hypoglycemia rates in hospitalized patients 1

Do not use sliding scale insulin alone as monotherapy if the patient has known diabetes – This leads to persistent hyperglycemia, though it may be appropriate for stress hyperglycemia in patients without diabetes 1

Target Glucose Range

• Maintain blood glucose 140–180 mg/dL (7.8–10.0 mmol/L) 1
• Stricter targets (80–180 mg/dL) may be considered perioperatively but don't improve outcomes and increase hypoglycemia 1